Mechanisms of p16INK4A inactivation in non small-cell lung cancers

S Gazzeri, V Gouyer, C Vour'Ch, C Brambilla… - Oncogene, 1998 - nature.com
… C20 antibody can thus be considered as a reliable antibody with high affinity for p16INK4A
protein and no false positives, whereas p16 INK4A (Pharmingen) immunostaining is more …

Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis

SA Belinsky, KJ Nikula… - Proceedings of the …, 1998 - National Acad Sciences
… The p16 INK4a (p16) tumor suppressor gene … lung cancer, the leading cause of cancer-related
deaths in the US We have determined the timing of this event in an animal model of lung

P16INK4a gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysis

L Tuo, S Sha, Z Huayu, K Du - Thoracic cancer, 2018 - Wiley Online Library
… frequency of P16 INK4a in serum or bronchoalveolar fluid (BAF)/sputum in lung cancer
patients has been widely discussed; however, the exact diagnostic performance of P16 INK4a as …

Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications

Y Liu, Q An, L Li, D Zhang, J Huang, X Feng… - …, 2003 - academic.oup.com
… Promoter hypermethylation of the p16 INK4a gene … lung cancer, using a modified protocol
of semi-nested methylation-specific-PCR (MSP). The results showed hypermethylated p16

Value of p16INK4a and RASSF1A Promoter Hypermethylation in Prognosis of Patients with Resectable Non–Small Cell Lung Cancer

J Wang, JJ Lee, L Wang, DD Liu, C Lu, YH Fan… - Clinical cancer …, 2004 - AACR
… non-small cell lung cancer. Our results indicate that p16 INK4a promoter hypermethylation
predicts a poor 5-year survival rates for patients with resectable non-small cell lung cancer, …

Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression

S Vonlanthen, J Heighway, MP Tschan, MM Borner… - Oncogene, 1998 - nature.com
Expression of p16INK4a/p16a and p19ARF/p16b is frequently altered in non-small cell lung
cancer and correlates with p53 overexpr Page 1 Expression of p16INK4a/p16a and p19ARF/…

p16 INK4A hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer

A Bearzatto, D Conte, M Frattini, N Zaffaroni… - Clinical Cancer …, 2002 - AACR
p16 INK4A inactivation, correlates with loss of protein expression, and represents a frequent
event in lung cancer. … Moreover, the fact that p16 INK4A methylation has also been found in …

Multiple Mechanisms of p16INK4A Inactivation in Non-Small Cell Lung Cancer Cell Lines

GI Shapiro, JE Park, CD Edwards, L Mao, A Merlo… - Cancer research, 1995 - AACR
… Most Rb-positive NSCLC lung cancer cells lines expressed no detectable p161N@(4@@…
A similar situation occurred in primary human lung cancers: p16INK4Aprotein was Un …

The reduced expression and aberrant methylation of p16INK4a in chromate workers with lung cancer

K Kondo, Y Takahashi, Y Hirose, T Nagao… - Lung Cancer, 2006 - Elsevier
… The p16 INK4a protein expression was examined in 30 chromate lung cancers, by which we
could measure the p16 … Twenty-five normal lung and bronchial tissues, adjacent to tumors …

p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer

DH Kim, HH Nelson, JK Wiencke, S Zheng… - Cancer research, 2001 - AACR
… The p16 INK4a protein inhibits cyclin-dependent kinase 4, a key regulator of progression
through the G 1 phase of the cell cycle. Methylation of CpG islands in the promoter region is an …